Mab-AR-9.6

N/A

Report date: 2025/01/15 14:27:31

Base Information

Drug NameMab-AR-9.6
Drug Alias NameMab-AR-9.6
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionMucin-16 inhibitors
TargetsMucin-16
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of Nebraska
China Registration ClassN/A

Develop Information

Inactive CompaniesQuest Pharmatech Inc
Active IndicationsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A